期刊文献+

结核性胸膜炎患者异烟肼胸腔积液浓度测定及胸膜透过性 被引量:6

Determination of isoniazide concentration in pleural effusion and its pleural permeability in patients with tuberculous pleurisy
下载PDF
导出
摘要 目的采用高效液相色谱法(HPLC)测量结核性胸膜炎患者胸腔积液和血浆中异烟肼浓度,并评价异烟肼从血液经胸膜的透过性。方法收集15名结核性胸膜炎患者第1天晨服300 mg异烟肼后2 h的胸腔积液,并采集第3天服药后2 h的血样和胸腔积液,建立HPLC方法进行样品检测,并计算异烟肼的胸膜透过率。结果第1天异烟肼在胸腔积液中的平均浓度是(1.156±1.190)μg/ml;第3天异烟肼在胸腔积液中的平均浓度是(1.920±1.294)μg/ml,在血浆中的平均浓度是(2.445±1.463)μg/ml;异烟肼从血浆进入胸腔积液的平均透过率是86.0%。结论大多数初治患者异烟肼的胸腔积液透过性较高,连续口服异烟肼可以达到有效治疗浓度,对于非耐药结核性胸膜炎不需要胸腔内单独注射异烟肼。 Objective To establish a high-performance liquid chromatography(HPLC)-based method for determining isoniazide concentration in pleural effusion and plasma of patients with tuberculous pleurisy,and evaluate the permeability of isoniazide from blood into pleural effusion.Methods We collected pleural effusion from 15 patients with tuberculous pleurisy 2 h after administration 300 mg isoniazide in the morning of day 1.Pleural effusion and plasma were obtained 2 h after isoniazide administration on day 3.Isoniazide concentration was measured using HPLC,and the penetration rate of isoniazide in pleural effusion was calculated.Results Isoniazide concentration in the pleural effusion averaged 1.156±1.190 μg/ml in the 15 patients at 2 h after isoniazide administration on day 1.On day 3,isoniazide concentration was 1.920±1.294 μg/ml in the pleural effusion and 2.445±1.463 μg/ml in the plasma,and the mean penetration rate of isoniazide from blood into the pleural effusion was 86.0%.Conclusion As isoniazide has a high penetration rate into the pleural effusion in most patients,continuous oral administration of isoniazid has been sufficient to achieve an effective treatment concentration,and intrapleural injection of isoniazide may seem unnecessary for non-drug-resistant tuberculosis pleurisy.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2012年第5期673-676,共4页 Journal of Southern Medical University
基金 广东省医院药学研究基金(2011A03) 南方医院院长基金(2009C002)
关键词 结核性胸膜炎 异烟肼 胸腔积液 透过性 tuberculous pleurisy pleural effusion high-performance liquid chromatography isoniazide permeability
  • 相关文献

参考文献16

  • 1马玙.提高我国结核性胸膜炎的诊治水平[J].结核病与胸部肿瘤,2009(2):132-134. 被引量:3
  • 2Davies CW,Gleeson FV,Davies RJ,et al.BTS guidelines for themanagement of pleural infection[J].Thorax,2003,58(7):ii18-8.
  • 3Light RW.Pleural disease[M].3rd.Baltimore:Williams andWilkins,1995:154-66.
  • 4中华医学会.临床诊疗指南:结核病分册[M].北京:人民卫生出版社,2009:10-2.
  • 5李家泰.临床药理学[M].2版.北京:人民卫生出版社,1998:1223.
  • 6Mitchison DA.Role of individual drugs in the chemotherapy oftuberculosi[s J].Int J Tuberc Lung Dis,2000,4:796-806.
  • 7Liapakis IE,Kottakis I,Light RW,et al.Pharmacokinetics andpharmacodynamics in the pleural space[M]//Pleural Disease.Baltimore:Williams and Wilkins,2004:999-1008.
  • 8金鸣,黄河,陈新山.反相高效液相色谱法测定血浆及尿液中的异烟肼[J].色谱,2002,20(5):442-445. 被引量:10
  • 9许亦鸣,陈冰,王洁,周秋云,朱文玉,李金恒.高效液相色谱法测定人血浆中异烟肼及乙酰异烟肼浓度[J].中国药房,2005,16(13):1001-1003. 被引量:13
  • 10Jutte PC,Rutgers SR,Van Altena R.Penetration of isoniazid,rifampicin and pyrazinamide in tuberculous pleural effusion andpsoas absces[s J].Int J Tuberc Lung,2004,8(11):1368-72.

二级参考文献21

  • 1陈冰,李金恒.反向点杂交法检测中国人N-乙酰化酶基因型[J].中国药理学通报,2004,20(11):1269-1272. 被引量:5
  • 2许亦鸣,陈冰,王洁,周秋云,朱文玉,李金恒.高效液相色谱法测定人血浆中异烟肼及乙酰异烟肼浓度[J].中国药房,2005,16(13):1001-1003. 被引量:13
  • 3焦小玲,王济民,王小森,杨毓章,肖跃平,爱民,任利平,马恩博,杨占斌.抗结核药不良反应的监测[J].药物流行病学杂志,1995,4(2):77-80. 被引量:13
  • 4Dahl ML, Sjoqvist F.Pharmacogenetic methods as a complement to therapeutic monitoring of antidepressants and neuroleptics[J]. Ther Drug Monit,2000,22(1) : 114.
  • 5Lennard L. Therapeutic drug monitoring of antimetabolic cytotoxic drugs[J] .BrJ Clin Pharmacol, 1999, 47(2) : 131.
  • 6Seifart HI, Gent WL, Parkin DP, et al. High- performance liquid chromatographic determination of isoniazid, acetylisoniazid and hydrazine in biological fluids[ J ]. J Chromatography B, 1995,674: 269.
  • 7Takeo D, Masami M, Tomokazu S. Correlation between acetylator phenotypes and genotypes of polymorphic arylamine N - acetyhransferase in human liver[J] .J Biological Chem , 1990,265:12 757.
  • 8Tomoko K, Yusuke T, Shinji C, et al. N - acetyltransferase 2 genotype correlated with isoniazid acetylationin Japanese tuberculous patients[J] .Biol Pharm Bull,2001,24(5) : 544.
  • 9Ray J, Gardiner 1, Marriott D. Managing anfitubercullosis drug therapy by therapeutic drug monitoring of fifampicin and isoniazid [ J ]. lntem Med J,2003,33:229.
  • 10ConteJR JE, Golden JA, McQuitty M, et al. Effects of gender, AIDS, and acetylator status on intrapulmonary concentrations of isoniazid[J]. Antimicrob Agents Chemother, 2002, 46(8) : 2358.

共引文献76

同被引文献59

引证文献6

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部